Selected Grants
Stimulating Access to Research in Residency (StARR) - NIAID
Inst. Training Prgm or CMECo-Principal Investigator · Awarded by National Institutes of Health · 2018 - 2029Advanced Immunobiology Traning Program for Surgeons
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2019 - 2029Stimulating Access to Research in Residency (StARR) - NHLBI
Inst. Training Prgm or CMECo-Principal Investigator · Awarded by National Heart, Lung, and Blood Institute · 2018 - 2028A place-based approach to geographic disparities in lung transplant (R01)
ResearchPrincipal Investigator · Awarded by Cleveland Clinic Foundation · 2023 - 2028Lung Transplant Clinical Trial Network (LT-CTN)
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2021 - 2028Complement Pathway Activation in Idiopathic Pulmonary Fibrosis and other Progressive Fibrosing Interstitial Lung Diseases (K23)
ResearchMentor · Awarded by National Heart, Lung, and Blood Institute · 2023 - 2028Lung Transplant Consortium - Data Coordinating Center
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2022 - 2027Integrated Biostatistical Training for CVD Research
Inst. Training Prgm or CMEMentor · Awarded by North Carolina State University · 2022 - 2027Transcriptional profiling of allograft tissues to define endotypes associated with CLAD progression
ResearchCo Investigator · Awarded by Cystic Fibrosis Foundation · 2025 - 2026Duke Program of Training in Pulmonary ReSearch to Promote, Engage and Retain Academic Researchers (PROSPER)
Inst. Training Prgm or CMEPrincipal Investigator · Awarded by National Heart, Lung, and Blood Institute · 2022 - 2026B Cell-Fibroblast Crosstalk Promotes Chronic GVHD of the Lung
ResearchCo-Mentor · Awarded by National Institutes of Health · 2024 - 2026Long Term Follow up of the Lung Transplant Outcomes Group Cohort
ResearchPrincipal Investigator · Awarded by University of Pennsylvania · 2019 - 2026Improving Lung Transplant Outcomes with Coping Skills and Physical Activity
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2019 - 2026Targeting Inflammation and Alloimmunity in Lung Transplant Recipients With Clazakizumab
Clinical TrialCo Investigator · Awarded by Massachusetts General Hospital · 2021 - 2025CTOT - CFF - Extension
ResearchPrincipal Investigator · Awarded by Cystic Fibrosis Foundation · 2021 - 2025The IGNITE II CC: Engagement, Coordination, Demonstration, and Dissemination
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2018 - 2025COPD Pulmonary Rehab GEMSSTAR Award
ResearchMentor · Awarded by National Institutes of Health · 2023 - 2025Club cell secretory protein to distinguish chronic allograft dysfunction risk in lung transplant recipients
ResearchCo Investigator · Awarded by Cystic Fibrosis Foundation · 2023 - 2024Understanding Long-term Respiratory Morbidity in Former Styrene-Exposed Workers
ResearchPrincipal Investigator · Awarded by Centers for Disease Control and Prevention · 2020 - 2024Duke CTSA (TL1) Year 5
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2018 - 2024Synthetic Control Arm for IPF
ResearchPrincipal Investigator · Awarded by Bristol-Myers Squibb Company · 2019 - 2024Unified Program for Therapeutics in Children
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2019 - 2024Early Posttransplant Intragraft Hyaluronan as an Independent Biomarker of CLAD Risk
ResearchSignificant Contributor · Awarded by Cystic Fibrosis Foundation · 2022 - 2024CTOT Long-Term Extension Study
ResearchPrincipal Investigator · Awarded by Cystic Fibrosis Foundation · 2019 - 2024Incyte INCB39110-214
Clinical TrialPrincipal Investigator · Awarded by Incyte Corporation · 2019 - 2024Cell-free DNA in the Blood and Lung Allograft Fluid: Understanding Association with Acute Rejection in Lung Transplant Recipients
ResearchPrincipal Investigator · Awarded by CareDx, Inc. · 2019 - 2023Postdoctoral Training in Genomic Medicine Research
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2017 - 2023Chronic Lung Allograft Dysfunction
ResearchPrincipal Investigator · Awarded by AstraZeneca AB · 2019 - 2023Genetics of Acute Rejection and Chronic Lung Allograft Dysfunction
ResearchPrincipal Investigator · Awarded by Cystic Fibrosis Foundation · 2019 - 2022Proof of Concept Treatment Interventions in a Rodent Model of the Rare Disease Bronchiolitis Obliterans
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2020 - 2022Club Cells and CCSP in the pathogenesis of CLAD/spatial transcriptomics
ResearchPrincipal Investigator · Awarded by Icahn School of Medicine at Mount Sinai · 2020 - 2021Hyaluronan in Acute Rejection and Chronic Allograft Dysfunction after Lung Transplantation - CTOT Ancillary
ResearchCo Investigator · Awarded by Mount Sinai School of Medicine · 2019 - 2021UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
Inst. Training Prgm or CMEMentor · Awarded by University of North Carolina - Chapel Hill · 2020 - 2021The Lung Transplant Clinical Trials Network (LT-CTN)
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2014 - 2021Interdisciplinary Training Program in Lung Disease
Inst. Training Prgm or CMECo-Principal Investigator · Awarded by National Institutes of Health · 2009 - 2021Immune Profiles to Better Understand Chronic Allograft Dysfunction and Successful Long-term Clinical Outcomes after Human Lung Transplantation
ResearchMentor · Awarded by National Institutes of Health · 2016 - 2021Impact of patient specific factors on CF lung transplant outcomes
FellowshipPrincipal Investigator · Awarded by Cystic Fibrosis Foundation Therapeutics, Inc. · 2018 - 2020Molecular Atlas of Lung Development - Data Coordinating Center
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2014 - 2020Premier IPF_2
ResearchPrincipal Investigator · Awarded by Boehringer Ingelheim Pharmaceuticals, Inc. · 2016 - 2019Do changes in bronchoalveolar fluid cells correlate with immune polarization, acute rejection, lung injury, or chronic lung allograft dysfunction (CLAD) after lung transplantation? CTOT
ResearchPrincipal Investigator · Awarded by Mount Sinai School of Medicine · 2018 - 2019Lung Tissue Gene Expression Profiling in Chronic Lung Allograft Dysfunction-CTOT
ResearchCo Investigator · Awarded by Mount Sinai School of Medicine · 2018 - 2019Thermo Lumos Tribrid High-Resolution Accurate-Mass Tandem Mass Spectrometer
EquipmentMajor User · Awarded by National Institutes of Health · 2018 - 2019Evaluation of the host immune response and viral molecular phenotype in lung transplant recipients with PTLD
ResearchCo Investigator · Awarded by Mount Sinai School of Medicine · 2017 - 2018Duke CTSA (UL1)
ResearchAssociate Director · Awarded by National Institutes of Health · 2013 - 2018Hyaluronan in Acute Rejection and Chronic Lung Allograft Dysfunction after Human Lung Transplantation
ResearchCo Investigator · Awarded by Mount Sinai School of Medicine · 2016 - 2017CTOT - Cell Free DNA
ResearchCo Investigator · Awarded by Mount Sinai School of Medicine · 2016 - 2017CTOT Ancillary Studies Fund Carry Forward BAL
ResearchPrincipal Investigator · Awarded by Mount Sinai School of Medicine · 2016 - 2017Obesity, Inflammation, and Lung Injury after Lung Transplantation
ResearchPrincipal Investigator · Awarded by Columbia University · 2013 - 2017Lung Repair and Regeneration Consortium Administrative Coordinating Center
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2012 - 2017Proteomics of flavorings-induced airway disease
ResearchPrincipal Investigator · Awarded by Centers for Disease Control and Prevention · 2014 - 2016CTOT Ancillary Studies Fund
ResearchPrincipal Investigator · Awarded by Mount Sinai School of Medicine · 2014 - 2016The Duke Multidisciplinary Training Program in Pediatric Lung Disease
Inst. Training Prgm or CMEFaculty Member · Awarded by National Institutes of Health · 2010 - 2016AZLI in lung transplant recipients
Clinical TrialPrincipal Investigator · Awarded by Gilead Sciences, Inc. · 2013 - 2015Telephone-based coping skills training for COPD
ResearchCo Investigator · Awarded by National Institutes of Health · 2000 - 2014RESULT Trial-REflux SUrgery in Lung Transplantation
Clinical TrialCo-Principal Investigator · Awarded by National Institutes of Health · 2010 - 2013Novel Cellular Immune Profiles to Predict Lung Disease Outcomes
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2011 - 2013Genetic Regulation of Lung Transplant Outcomes
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2008 - 2013CTSA UL
ResearchCo Investigator · Awarded by National Institutes of Health · 2006 - 2012Stem Cells to Enhance Bronchiolar Reparative Capacity
ResearchCo Investigator · Awarded by National Institutes of Health · 2007 - 2011Interdisciplinary Training Program in Lung Disease
Inst. Training Prgm or CMEParticipating Faculty Member · Awarded by National Institutes of Health · 1982 - 2009Role of CXC chemokines at the innate-adaptive interface of alloimmune lung injury
FellowshipPrincipal Investigator · Awarded by National Institutes of Health · 2007 - 2008Innate immune responses in obliterative bronchiolitis
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2002 - 2007Role Of Adhesion Molecules In Allograft Rejection
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1996 - 1999External Relationships
- AbbVie, Inc.
- Boehringer Ingleheim
- Bristol-Myers Squibb
- Mallinckrodt Pharmaceuticals
- Sanofi
- Up To Date Inc/Wolters Kluwer Health
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.